9 research outputs found

    Extended family history of type 1 diabetes inHLA-predisposed children with and without islet autoantibodies

    Get PDF
    Objective The aim of this study was to explore the extended family history of type 1 diabetes in children at genetic risk and define the impact of a positive family history on the development of islet autoimmunity and type 1 diabetes. Methods The subjects were participants in The Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study and carried increased HLA-conferred risk for type 1 diabetes. The case children (N = 343) were positive for at least one islet autoantibody, and the control children (N = 343) matched by age, gender and class II HLA genotype were negative for islet autoantibodies at the time of data collection. Extended family history of type 1 diabetes was obtained by using a structured questionnaire. Results Among children who were autoantibody positive and progressed to type 1 diabetes 62.2% (28/45) had at least one relative with type 1 diabetes. Interestingly, 57.8% of these children (26/45) had such a relative outside the nuclear family compared to 30.7% of children with no autoantibodies (P= .001), 35.2% of those with only classical islet cell antibodies (P= .006), and 35.2% of non-progressors with biochemical autoantibodies (P= 0.011). A positive history of type 1 diabetes in the paternal extended family was more common in children with multiple biochemical autoantibodies compared to those with only one biochemical autoantibody (P= .010). No association between the specificity of the first appearing autoantibody and family history of the disease was found. Conclusions Type 1 diabetes in relatives outside the nuclear family is a significant risk factor for islet autoimmunity and progression to clinical disease in HLA susceptible children.Peer reviewe

    Extended family history of type 1 diabetes inHLA-predisposed children with and without islet autoantibodies

    Get PDF
    Objective The aim of this study was to explore the extended family history of type 1 diabetes in children at genetic risk and define the impact of a positive family history on the development of islet autoimmunity and type 1 diabetes. Methods The subjects were participants in The Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study and carried increased HLA-conferred risk for type 1 diabetes. The case children (N = 343) were positive for at least one islet autoantibody, and the control children (N = 343) matched by age, gender and class II HLA genotype were negative for islet autoantibodies at the time of data collection. Extended family history of type 1 diabetes was obtained by using a structured questionnaire. Results Among children who were autoantibody positive and progressed to type 1 diabetes 62.2% (28/45) had at least one relative with type 1 diabetes. Interestingly, 57.8% of these children (26/45) had such a relative outside the nuclear family compared to 30.7% of children with no autoantibodies (P= .001), 35.2% of those with only classical islet cell antibodies (P= .006), and 35.2% of non-progressors with biochemical autoantibodies (P= 0.011). A positive history of type 1 diabetes in the paternal extended family was more common in children with multiple biochemical autoantibodies compared to those with only one biochemical autoantibody (P= .010). No association between the specificity of the first appearing autoantibody and family history of the disease was found. Conclusions Type 1 diabetes in relatives outside the nuclear family is a significant risk factor for islet autoimmunity and progression to clinical disease in HLA susceptible children.</div

    InDEx – Industrial Data Excellence

    Get PDF
    InDEx, the Industrial Data Excellence program, was created to investigate what industrial data can be collected, shared, and utilized for new intelligent services in high-performing, reliable and secure ways, and how to accomplish that in practice in the Finnish manufacturing industry.InDEx produced several insights into data in an industrial environment, collecting data, sharing data in the value chain and in the factory environment, and utilizing and manipulating data with artificial intelligence. Data has an important role in the future in an industrial context, but data sources and utilization mechanisms are more diverse than in cases related to consumer data. Experiences in the InDEx cases showed that there is great potential in data utili zation.Currently, successful business cases built on data sharing are either company-internal or utilize an existing value chain. The data market has not yet matured, and third-party offerings based on public and private data sources are rare. In this program, we tried out a framework that aimed to securely and in a controlled manner share data between organizations. We also worked to improve the contractual framework needed to support new business based on shared data, and we conducted a study of applicable business models. Based on this, we searched for new data-based opportunities within the project consortium. The vision of data as a tradeable good or of sharing with external partners is still to come true, but we believe that we have taken steps in the right direction.The program started in fall 2019 and ended in April 2022. The program faced restrictions caused by COVID-19, which had an effect on the intensity of the work during 2020 and 2021, and the program was extended by one year. Because of meeting restrictions, InDEx collaboration was realized through online meetings. We learned to work and collaborate using digital tools and environments. Despite the mentioned hindrances, and thanks to Business Finland’s flexibility, the extension time made it possible for most of the planned goals to be achieved.This report gives insights in the outcomes of the companies’ work within the InDEx program. DIMECC InDEx is the first finalized program by the members of the Finnish Advanced Manufacturing Network (FAMN, www.famn.fi).</p

    Materiaali pedagogiseen dokumentointiin varhaiskasvatuksessa

    No full text
    Tämän kehittämistyön tarkoituksena oli kehittää Ruskon kunnassa sijaitsevan päiväkodin pedagogista dokumentointia lapsilähtöisemmäksi. Kehittämisen tuloksena syntyi lapsen osallisuutta pedagogisessa dokumentoinnissa tukeva materiaali, joka sisältää monipuolisia työkaluja ja toimintaideoita varhaiskasvatussuunnitelman eri oppimisen alueilta. Materiaalin tavoitteena on innostaa varhaiskasvattajia tarjoamaan lapsille enemmän mahdollisuuksia osallisuuteen varhaiskasvatuksen suunnittelussa, toteutuksessa ja arvioinnissa. Kehittämistyön teoreettinen viitekehys koostuu varhaiskasvatuksen pedagogisen toiminnan lähtökohtien tarkastelusta sekä lapsen osallisuuden merkityksen huomioimisesta osana varhaiskasvatusta ja pedagogista dokumentointia. Tässä opinnäytetyössä kehittämismenetelminä käytettiin tiedonhakua, tarveanalyysia, dialogista keskustelua, osallistuvaa havainnointia, kokeilemalla kehittämistä sekä palautteen keruuta. Kehittämistyön tuotoksena muodostunut materiaali sisältää monipuolisia harjoitteita ja toimintaehdotuksia tukemaan 1–5-vuotiaiden lasten osallisuutta pedagogisessa dokumentoinnissa. Materiaali koostuu pienestä johdannosta pedagogiseen dokumentoinnin maailmaan ja toimintaan varhaiskasvatuksessa, jota seuraa ikäryhmittäin jaoteltuja lomakkeita, kysymyslistoja havainnoinnin tueksi sekä toimintaehdotuksia päiväkodin arkeen

    Sources of dietary gluten in the first 2 years of life and associations with celiac disease autoimmunity and celiac disease in Swedish genetically predisposed children : The Environmental Determinants of Diabetes in the Young (TEDDY) study

    No full text
    Background High gluten intake is associated with increased risk of celiac disease (CD) in children at genetic risk. Objectives We aimed to investigate if different dietary gluten sources up to age 2 y confer different risks of celiac disease autoimmunity (CDA) and CD in children at genetic risk. Methods Three-day food records were collected at ages 6, 9, 12, 18, and 24 mo from 2088 Swedish genetically at-risk children participating in a 15-y follow-up cohort study on type 1 diabetes and CD. Screening for CD was performed with tissue transglutaminase autoantibodies (tTGA). The primary outcome was CDA, defined as persistent tTGA positivity. The secondary outcome was CD, defined as having a biopsy specimen showing Marsh score >= 2 or an averaged tTGA level >= 100 Units. Cox regression adjusted for total gluten intake estimated HRs with 95% CIs for daily intake of gluten sources. Results During follow-up, 487 (23.3%) children developed CDA and 242 (11.6%) developed CD. Daily intake of 18.3 g) at age 12 mo was associated with increased risk of both CDA (HR: 1.47; 95% CI: 1.05, 2.05; P = 0.023) and CD (HR: 1.79; 95% CI: 1.10, 2.91; P = 0.019) compared with no intake. At age 18 mo, milk cereal drink was associated with an increased risk of CD (HR: 1.16; 95% CI: 1.00, 1.33; P = 0.047) per 200-g/d increased intake. No association was found for other gluten sources up to age 24 mo and risk of CDA or CD. Conclusions High daily intakes of bread at age 12 mo and of milk cereal drink during the second year of life are associated with increased risk of both CDA and CD in genetically at-risk children.Peer reviewe
    corecore